These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32339438)

  • 41. Afirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid Nodules.
    Endo M; Nabhan F; Porter K; Roll K; Shirley LA; Azaryan I; Tonkovich D; Perlick J; Ryan LE; Khawaja R; Meng S; Phay JE; Ringel MD; Sipos JA
    Thyroid; 2019 Aug; 29(8):1115-1124. PubMed ID: 31154940
    [No Abstract]   [Full Text] [Related]  

  • 42. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
    An JH; Song KH; Kim SK; Park KS; Yoo YB; Yang JH; Hwang TS; Kim DL
    Clin Endocrinol (Oxf); 2015 May; 82(5):760-6. PubMed ID: 25109485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes of Indeterminate Thyroid Nodules Managed Nonoperatively after Molecular Testing.
    Zhu CY; Donangelo I; Gupta D; Nguyen DT; Ochoa JE; Yeh MW; Livhits MJ
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1240-e1247. PubMed ID: 33394039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Probability of malignancy and molecular alterations as determined by ThyroSeq v3 genomic classifier in Bethesda Category IV.
    Tjendra Y; Kerr DA; Zuo Y; Menendez SG; Jorda M; Gomez-Fernandez C; Velez Torres JM
    Cancer Cytopathol; 2023 Sep; 131(9):586-595. PubMed ID: 37358081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).
    Zhou H; Baloch ZW; Nayar R; Bizzarro T; Fadda G; Adhikari-Guragain D; Hatem J; Larocca LM; Samolczyk J; Slade J; Rossi ED
    Cancer Cytopathol; 2018 Jan; 126(1):20-26. PubMed ID: 28941185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular Characterization of Sporadic Pediatric Thyroid Carcinoma with the DNA/RNA ThyroSeq v2 Next-Generation Sequencing Assay.
    Picarsic JL; Buryk MA; Ozolek J; Ranganathan S; Monaco SE; Simons JP; Witchel SF; Gurtunca N; Joyce J; Zhong S; Nikiforova MN; Nikiforov YE
    Pediatr Dev Pathol; 2016; 19(2):115-22. PubMed ID: 26367451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Indeterminate nodules by the Bethesda system for reporting thyroid cytopathology in Israel: Frequency, and risk of malignancy after reclassification of follicular thyroid neoplasm with papillary-like features.
    Rosenblum RC; Shtabsky A; Marmor S; Trejo L; Yaish I; Barnes S; Yehuda M; Stern N; Silman Z; Tordjman KM
    Eur J Surg Oncol; 2019 Jul; 45(7):1182-1187. PubMed ID: 30928335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
    Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
    Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
    Strickland KC; Howitt BE; Barletta JA; Cibas ES; Krane JF
    Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive Value of a Genomic Classifier in Indeterminate Thyroid Nodules Based on Nodule Size.
    Dublin JC; Papazian M; Zan E; Oweity T; Sun W; Jacobson A; Patel K; Brandler TC; Givi B
    JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):53-60. PubMed ID: 34734965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How Effective is the Use of Molecular Testing in Preoperative Decision Making for Management of Indeterminate Thyroid Nodules?
    Steinmetz D; Kim M; Choi JH; Yeager T; Samuel K; Khajoueinejad N; Buseck A; Imtiaz S; Fernandez-Ranvier G; Lee D; Owen R; Taye A
    World J Surg; 2022 Dec; 46(12):3043-3050. PubMed ID: 36167834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative Molecular Markers in Thyroid Nodules.
    Sahli ZT; Smith PW; Umbricht CB; Zeiger MA
    Front Endocrinol (Lausanne); 2018; 9():179. PubMed ID: 29720964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization and Clinical Significance of EIF1AX Mutations and Co-Mutations in Cytologically Indeterminate Thyroid Nodules: A 5-Year Retrospective Analysis.
    Gargano SM; Badjatia N; Nikolaus Y; Peiper SC; Wang ZX
    Acta Med Acad; 2021 Apr; 50(1):4-12. PubMed ID: 34075760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular Testing for Indeterminate Thyroid Nodules: Association of Negative Predictive Value With Nodule Size.
    Barnes AB; Justice-Clark T; Li W; Randle RW
    Am Surg; 2022 Nov; 88(11):2745-2751. PubMed ID: 35723175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
    Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and
    Hernandez-Prera JC; Valderrabano P; Creed JH; de la Iglesia JV; Slebos RJC; Centeno BA; Tarasova V; Hallanger-Johnson J; Veloski C; Otto KJ; Wenig BM; Yoder SJ; Lam CA; Park DS; Anderson AR; Raghunand N; Berglund A; Caudell J; Gerke TA; Chung CH
    Thyroid; 2021 Jan; 31(1):36-49. PubMed ID: 32689909
    [No Abstract]   [Full Text] [Related]  

  • 57. Assessing Bias and Limitations of Clinical Validation Studies of Molecular Diagnostic Tests for Indeterminate Thyroid Nodules: Systematic Review and Meta-Analysis.
    DiGennaro C; Vahdatzad V; Jalali MS; Toumi A; Watson T; Gazelle GS; Mercaldo N; Lubitz CC
    Thyroid; 2022 Oct; 32(10):1144-1157. PubMed ID: 35999710
    [No Abstract]   [Full Text] [Related]  

  • 58. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
    Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
    Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preoperative cytologic interpretation of noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a 1-year multi-institutional experience.
    Lastra RR; Birdsong G; Hwang DH; Jorda M; Kerr DA; McGrath C; Odronic S; Rao R; VanderLaan PA; Walker JW; Antic T
    J Am Soc Cytopathol; 2018; 7(2):79-85. PubMed ID: 31043256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgical Outcomes of Thyroid Nodules Positive for Gene Expression Alterations Using ThyroSeq V3 Genomic Classifier.
    Salameh S; Rajab M; Forest VI; Pusztaszeri M; Payne RJ
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.